ABEONA THERAPEUTICS INC. (ABEO) AI Dilution Summary

Estimated cash was $124,501,029 as of 2026-10-01, rolled forward from $146,826,000 at 2026-06-30 against estimated monthly burn of $5,832,000. The company's active funding facility is its at-the-market (ATM) program with Jefferies LLC, authorised to $75,000,000. Dilution here is driven primarily by capacity registered in dollars.